Links to all abstracts Hammersmith 2017.

OC1 The challenge of second line immunotherapy in Graves’ ophthalmopathy

OC2 Emergency Orbital Decompression is not a definitive treatment for Dysthyroid Optic Neuropathy (DON)

OC3 Advanced medullary thyroid cancer – when to start treatment?

OC4 Resistant hypercalcaemia in pregnancy – medicine to surgery

OC5 The anomalous goitre: an unusual presentation of multi-nodular goitre

X001 Hypercalcaemia and Primary hyperparathyroidism in pregnancy

X002 An unusual case of asymptomatic primary adrenal insufficiency due to bilateral adrenal haemorrhagic infarcts

X003 The forgotten neoplasia of MEN-1 syndrome: thymic neuroendocrine tumours

X004 Familial hypocalciuric hypercalcaemia – a case report and review of the literature

X005 Amiodarone-induced thyrotoxicosis type 2 (AIT2)

X006 Alcoholic pseudo-Cushing’s syndrome: mimics both the biochemistry and clinical features of Cushing’s syndrome

X007 Heparin-induced hyperkalaemia due to hyporeninaemic hypoaldosteronism

X008 The challenges of investigating adrenal insufficiency in patients with immunotherapy related adverse reactions requiring glucocorticoid treatment

X009 Diagnostic and therapeutic role of GnRH analogue in postmenopausal hyperandrogenism

X010 A Tale of Two Brothers with Neuroendocrine Tumours

X011 Challenges in the management of a rapidly growing dedifferentiated parathyroid carcinoma

X012 The anomalous goitre: an unusual presentation of multi-nodular goitre

X013 An Unusual Presentation of Partial Empty Sella Syndrome and Arnold Chiari Type 1 Malformation

X014 An unusual cause of leg weakness

X015 Single presentation, two lifesaving diagnosis’- Simultaneous new presentation of diabetic ketoacidosis and primary adrenal insufficiency

X016 Parathyroid nuclear medicine localisation - an unusual ectopic gland? 

X017 Advanced medullary thyroid cancer – when to start treatment?

X018 Hurthle Cell Tumour - A case of delayed metastatic disease causing abnormal thyroid function, acromegaly and hypercalcaemia

X019 Persistently elevated plasma metanephrine levels in a patient with MEN2 – when to diagnose a phaeochromocytoma?

X020 Unmasking of concurrent autoimmune disease or the emergence of Graves’ precipitated by Adalimumab (Humira)?

X021 Paraneoplastic thyrotoxicosis secondary to advanced non-seminomatous germ cell tumour

X022 The challenge of second line immunotherapy in Graves’ ophthalmopathy

X023 Resistant hypercalcaemia in pregnancy – medicine to surgery

X024 Incidental phaeochromocytoma in an unsuspecting urological setting

X025 Thyrotoxic cardiomyopathy – a serious consequence of uncontrolled Graves thyrotoxicosis

X026 Two cases of hypophysitis presenting as pseudomacroadenoma and hyponatraemia

X027 The success of multimodality treatment in metastatic medullary thyroid cancer

X028 Bilateral adrenal histoplasmosis in an immunocompetent man

X029 Autoimmune primary adrenal insufficiency masked by chronic steroid inhaler use

X030 A rare presentation of TSH-secreting Pituitary macroadenoma (TSHoma) alongside an Autoimmune Primary Hypothyroidism-The management challenge

X031 Diffusion-weighted Magnetic Resonance Imaging (DWI MRI) provides a quantitative measure of disease activiy and can be used as an adjunct to clinical assessment in Graves’ Orbitopathy (GO)

X032 Emergency Orbital Decompression is not a definitive treatment for Dysthyroid Optic Neuropathy (DON)

X033 Two cases of Primary thyroid lymphoma in hypothyroid patients presenting as goitres

X034 A challenging case of radioiodine-refractory Graves’ disease

X035 Percutaneous microwave ablation of adrenal remnant tissue. A novel treatment modality for persistent Cushing’s disease

X036 Erectile Dysfunction – An Under-Recognised Presentation of Acromegaly

X037 Pheochromocytoma

X038 How relevant is aldosterone and cortisol co-secretion?

X039 Iatrogenic nephrogenic diabetes insipidus secondary to demeclocycline misuse

X040 Optimising Follicular Growth for Oocyte Retrieval during IVF Treatment

X041 Fragile X premutation: A known under-diagnosed aetiology for premature ovarian insufficiency

X042 Fluconazole in the treatment of Cushing’s disease